首页 > 科研成果 > 发表论文 >
发表论文
预约就诊
021-5169 9696
SCI论文

权威SCI杂志论文

1.Xie WF, Kondo S, Sandell LJ. Regulation of the mouse cartilage-derived retinoic acid-sensitive protein gene by the transcription factor AP-2. J Biol Chem, 1998, 273(9):5026-5032.
2.Xie WF, Zhang X, Sakano S, Lefebvre V, Sandell LJ. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res, 1999, 14(5):757-763.
3.Shi J, Wu C, Lin Y, Chen YX, Zhu L, Xie WF*. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Am J Gastroenterol, 2006, 101(7):1529-1538. IF=5.608.

4.Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, Hou JL, Deng X, Zhang JP, Han ZG, Xie WF*. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology. 2008, 48(5):1528-1539. IF=11.355.
5.Hu PF, Chen H, Zhong W, Lin Y, Zhang X, Chen YX, Xie WF*. Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. J Hepatol, 2009, 51(1):102-113. IF=7.818.
6.Zhong W, Shen WF, Ning BF, Hu PF, Lin Y, Yue HY, Yin C, Hou JL, Chen YX, Zhang JP, Zhang X, Xie WF*. Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats. Hepatology, 2009, 50(5):1524-1536. IF=10.840
7.Yue HY, Yin C, Hou JL, Zeng X, Chen YX, Zhong W, Hu PF, Deng X, Tan YX, Zhang JP, Ning BF, Shi J, Zhang X, Wang HY, Lin Y, Xie WF*. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats. Gut, 2010, 59(2):236-246. IF=10.614
8.Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, Wang HY, Xie WF*. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res, 2010, 70(19):7640-7651. IF=8.234
9.Zhu CP, Shi J, Chen YX, Xie WF*, Lin Y*. Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis. Radiother Oncol, 2011, 99(2):108-113. IF=5.580
10.Xu W, Shi J, Zeng X, Li X, Xie WF, Guo J, Lin Y*. EUS elastography for the differentiation of benign and malignant lymph nodes: a meta-analysis. Gastrointest Endosc, 2011, 74(5):1001-1009. IF=4.878
11.Zeng X, Lin Y, Yin C, Zhang X, Ning BF, Zhang Q, Zhang JP, Qiu L, Qin XR, Chen YX, Xie WF*. Recombinant adenovirus carrying the hepatocyte nuclear factor-1α gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology, 2011, 54(12):2036-2047. IF=11.665
12.Xu WP, Yi M, Li QQ, Zhou WP, Cong WM, Yang Y, Ning BF, Yin C, Huang ZW, Wang J, Qian H, Jiang CF, Chen YX, Xia CY, Wang HY, Zhang X, Xie WF*. Perturbation of miR-370-LIN28A-NF-κB regulatory circuit contributes to the development of hepatocellular carcinoma. Hepatology, 2013, 58(6):1977-1991. IF=11.190
13.Yin C, Wang PQ, Xu WP, Yang Y, Zhang Q, Ning BF, Zhang PP, Zhou WP, Xie WF, Chen WS, Zhang X*. Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region. Hepatology. 2013, 58(6):1964-1976. IF=11.190
14.Ning BF, Ding J, Liu J, Yin C, Xu WP, Cong WM, Zhang Q, Chen F, Han T, Deng X, Wang PQ, Jiang CF, Zhang JP, Zhang X, Wang HY, Xie WF**. Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression. Hepatology, 2014, 60(5):1607-1619.  IF=11.190
15.Xu WH, Hu HG, Tian Y, Wang SZ, Li J, Li JZ, Deng X, Qian H, Qiu L, Hu ZL, Wu QY, Chai YF, Guo C, Xie WF*, Zhang JP*. Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis. Hepatology, 2014, 60(2):648-660.  IF=11.190
16.Wang J, Zhu CP, Hu PF, Qian H, Ning BF, Zhang Q, Chen F, Liu J, Shi B, Zhang X, Xie WF*. FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition. Carcinogenesis, 2014, 35(11):2576-2583. IF=5.266
17.Qian H, Deng X, Huang ZW, Wei J, Ding CH, Feng RX, Zeng X, Chen YX, Ding J, Qiu L, Hu ZL, Zhang X, Wang HY, Zhang JP, Xie WF*. An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells. Cell Res. 2015, 25(8):930-945. IF=12.413

 

其他SCI论文

1.Xie WF, Zhang X, Sandell LJ. The 2.2 kb Promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic Mice. Matrix Biol, 2000, 19(6):501-509.
2.Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer, 2005,92(3):607-612.  IF=4.112
3.Lin Y, Xie WF, Chen YX, Zhang X, Zeng X, Qiang H, Chen WZ, Yang XJ, Han ZG, Zhang ZB. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes. Liver Int, 2005, 25(4):796-807.  IF=1.766
4.Chen YX*, Lu CH, Xie WF, Zhang XR, Zhang ZB, Wei LX, Jin YX, Guo YJ. Effects of ribozyme targeting platelet-derived growth factor receptor beta subunit gene on the proliferation and apoptosis of hepatic stellate cells in vitro. Chin Med J (Engl), 2005, 118(12):982-988. IF=0.561
5.Qiang H, Lin Y, Zhang X, Zeng X, Shi J, Chen YX, Yang MF, Han ZG, Xie WF. Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Liver Int, 2006, 26(9):1126-1137. IF=2.344.
6.Chen SW, Chen YX, Shi J, Lin Y, Xie WF. The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig Dis Sci, 2006, 51(12):2225-2234. IF=1.448.
7.Pan Q, Zhang ZB, Zhang X, Shi J, Chen YX, Han ZG, Xie WF. Gene expression profile analysis of the spontaneous reversal of rat hepatic fibrosis by cDNA microarray. Dig Dis Sci, 2007, 52(10):2591-2600. IF=1.319.
8.Chen SW, Zhang XR, Wang CZ, Chen WZ, Xie WF, Chen YX. RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats. Liver Int, 2008, 28(10):1446-1457. IF=2.908.
9.Deng X, Chen YX, Zhang X, Zhang JP, Yin C, Yue HY, Lin Y, Han ZG, Xie WF. Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte-like cells. J Cell Physiol, 2008, 217(1):138-144. IF=4.313.
10.Chen SW, Chen YX, Zhang XR, Qian H, Chen WZ, Xie WF. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats. Gene Ther. 2008, 15(21):1424-1435. IF=4.492.
11.Hu PF, Zhu YW, Zhong W, Chen YX, Lin Y, Zhang X, Yin C, Yue HY, Xie WF. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells. J Gastroenterol Hepatol, 2008, 23(12):1917-1925. IF=2.275.
12.Yang XJ, Lin Y, Zeng X, Shi J, Chen YX, Shen JW, Xie WF. A minimally invasive alternative for managing large pancreatic duct stones using a modified expandable metal mesh stent. Pancreatology, 2009, 9(1-2):111-115. IF=2.195
13.Zhang Y, Chen QB, Gao ZY, Xie WF. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses. Aliment Pharmacol Ther, 2009, 29(11):1155-1164. IF=3.825
14. Xu J, Lin Y, Wang YP, Chen YX, Shi B, Lu J, Xie WF. Hepatitis B virus DNA in patients with hepatitis B-related liver cirrhosis with or without hepatocellular carcinomas: a matched case-control study. J Dig Dis, 2009, 10(2):138-144. IF=1.791
15.Shi J, Li Z, Zeng X, Lin Y, Xie WF. Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials. Hepatol Res, 2009, 39(9):865-873. IF=1.540
16.Xu J, Shi J, Wang YP, Lin Y, Chen YX, Lu J, Zeng X, Xie WF. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis. Med Sci Monit, 2009, 15(6):CR274-279. IF=1.543
17.Wang YP, Shi B, Chen YX, Xu J, Jiang CF, Xie WF. Drug-induced liver disease: an 8-year study of patients from one gastroenterological department. J Dig Dis, 2009, 10(3):195-200. IF=1.791
18.Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma. J Gastroenterol Hepatol, 2009, 24(1):55-62. IF=2.317
19.Zhang ZQ, Shi B, Wu GQ, Qin KR, Jiang ZL, Zhu L. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats. Eur J Pharmacol, 2009, 613(1-3):108-113. IF=2.585
20.Wu C, Luo Z, Chen X, Wu C, Yao D, Zhao P, Liu L, Shi B, Zhu L. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Oncol Rep, 2009, 21(6):1429-1437. IF=1.588
21.Hu PF, Xie WF. Targeted RNA interference for hepatic fibrosis. Expert Opin Biol Ther, 2009, 9(10):1305-1312. IF=3.215
22.Wang W, Shi J, Xie WF. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int, 2010, 30(5):741-749. IF=3.840
23.Wu HJ, Zhang ZQ, Yu B, Liu S, Qin KR, Zhu L. Pressure activates Src-dependent FAK-Akt and ERK1/2 signaling pathways in rat hepatic stellate cells. Cell Physiol Biochem, 2010, 26(3):273-280. IF=3.585
24.Li WQ, Chen C, Xu MD, Guo J, Li YM, Xia QM, Liu HM, He J, Yu HY, Zhu L. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J, 2011, 278(9):1522-1532. IF= 3.790
25.Chen C, Wu CQ, Zhang ZQ, Yao DK, Zhu L. Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp Cell Res, 2011, 317(12):1714-1725. IF=3.580
26.Song CY, Zeng X, Chen SW, Hu PF, Zheng ZW, Ning BF, Shi J, Xie WF, Chen YX. Sophocarpine alleviates non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol, 2011, 26(4):765-774. IF=2.865
27.Zhang Y, Shi J, Shi B, Song CY, Xie WF, Chen YX. Self-expanding metallic stent as a bridge to surgery versus emergency surgery for obstructive colorectal cancer: a meta-analysis. Surg Endosc, 2012, 26(1):110-119. IF=4.013
28.Teng JF, Zeng X, Shi J, Xie WF, Lin Y. A huge retroperitoneal liposarcoma presenting as a hepatic space-occupying lesion: A case report. J Dig Dis, 2012,13(2):120-122. IF=1.589
29.Zhang Y, Shi J, Shi B, Song CY, Xie WF, Chen YX. Comparison of efficacy between uncovered and covered self-expanding metallic stents in malignant large bowel obstruction: a systematic review and meta-analysis. Colorectal Dis, 2012, 14(7):e367-374. IF=2.927
30.Chen J, Shi J, Xie WF, Zeng X, Lin Y. Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients. Int J Infect Dis, 2012, 16(10):e748-752. IF=1.938
31.Wang XL, Cai HP, Ge JH, Su XF. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma. World J Gastroenterol, 2012, 18(20):2540-2544. IF=2.471
32.Xu W, Shi J, Li X, Zeng X, Lin Y. Endoscopic ultrasound elastography for differentiation of benign and malignant pancreatic masses: a systemic review and meta-analysis. Eur J Gastroenterol Hepatol, 2013, 25(2):218-224. IF=2.152
33.Song CY, Shi J, Zeng X, Zhang Y, Xie WF, Chen YX. Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway. Toxicol In Vitro, 2013, 27(3):1065-1071.  IF= 3.207
34.Fan TT, Hu PF, Wang J, Wei J, Zhang Q, Ning BF, Yin C, Zhang X, Xie WF, Chen YX, Shi B. Regression effect of hepatocyte nuclear factor 4α on liver cirrhosis in rats. J Dig Dis, 2013, 14(6):318-327. IF= 1.924
35.Shi YC, Zhao H, Yin C, Zeng X, Zhang Q, Xu WP, Wei J, Chen F, Xie WF. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades. Dig Liver Dis, 2013, 45(10):844-851. IF=2.889
36.Li X, Xu W, Shi J, Lin Y, Zeng X*. Endoscopic ultrasound elastography for differentiating between pancreatic adenocarcinoma and inflammatory masses: a meta-analysis. World J Gastroenterol, 2013, 19(37):6284-6291. IF=2.433
37.Qian H, Shi J, Fan TT, Lv J, Chen SW, Song CY, Zheng ZW, Xie WF, Chen YX. Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats. World J Gastroenterol 2014, 20(7):1822-1832. IF=2.433
38.Xu WP, Zhang X, Xie WF*. Differentiation therapy for solid tumors. J Dig Dis, 2014, 15(4):159-165. IF= 1.924
39.Gong XH, Chen C, Hou P, Zhu SC, Wu CQ, Song CL, Ni W, Hu JF, Yao DK, Kang JH, Zhu L. Overexpression of miR-126 inhibits the activation and migration of HSCs through targeting CRK. Cell Physiol Biochem, 2014, 33(1):97-106. IF= 3.55
40.Zhu CP, Wang J, Shi B, Hu PF, Ning BF, Zhang Q, Chen F, Chen WS, Zhang X, Xie WF*. The transcription factor FOXA2 suppresses gastric tumorigenesis in vitro and in vivo. Dig Dis Sci, 2015, 60(1):109-117.    IF=2.550
41.Song CY, Zeng X, Wang Y, Shi J, Qian H, Zhang Y, Fang JQ, Sheng X, Zheng JM*, Chen YX*. Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis. J Gastroenterol Hepatol, 2015, 30(2):405-412.
42.Zhu C, Ji M, Dai W, Ye C, Hu Z, Shi J, Zeng X, Lin Y*. Clinicopathological characteristics of Chinese colorectal cancer patients under 30 years of age: implication in diagnosis and therapy. Curr Cancer Drug Targets, 2015, 15(1):27-34.
43.Dai WP, Zhao J, Tang N, Wu KM, Ye CH, Shi J, Lu CH, Ning BF, Zhang JP, Zeng X, Lin Y*. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signaling pathway. Liver Int, 2015, 35(4):1234-1243.
44.Han J, Yi J, Liang F, Jiang B, Xiao Y, Gao S, Yang N, Hu H, Xie WF, Chen W*. X-3, a mangiferin derivative, stimulates AMP-activated protein kinase and reduces hyperglycemia and obesity in db/db mice. Mol Cell Endocrinol, 2015, 405:63-73.
45.Lu CH, Hou QR, Deng LF, Fei C, Xu WP, Zhang Q, Wu KM, Ning BF, Xie WF, Zhang X*. MicroRNA-370 attenuates hepatic fibrogenesis by targeting smoothened. Dig Dis Sci, 2015,  60(7):2038-2048.